Jornal de Oncologia Clínica e Experimental

Relato de caso

Influence of Long-term Abemaciclib, A New CDK 4/6 Inhibitor: Decrease in Liver Metastasis in a Patient Suffering from Metastatic Breast Cancer

• Zorn O, Miller J and Heirler F

Relato de caso

Influence of Abemaciclib, a New CDK 4/6 Inhibitor, Decrease in Potassium Electrollytes and Urea in a Patient Suffering from Metastatic Breast Cancer

• Zorn O and Heirler F